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Abstract 
Background: Alveolar soft part sarcoma (ASPS) is a rare malignant neoplasm originating from soft tissue. It 
was initially described as a distinctive clinical entity by Christopherson et al. in 1952. The peak age of 
incidence is between 15 and 35 years with slight sex predominance among women. The most common sites 
involved include extremities and trunk and in young adults and head and neck in  children.  ASPS is  a  slow-
growing tumor with unusual patterns of metastasis which runs a poor prognosis. The aim of this article was to 
present a case of ASPS of retroperitoneal origin along with its diagnostic and therapeutic workups.  
Case Report: A 31-year-old patients with a chief complain of an abdominal mass in right lower quadrant, underwent 
surgical resection as a neuroendocrine tumor according to pre-operative imaging studies. Pathology reported the 
lesion as ASPS. The patient refused adjuvant chemotherapy and unfortunately he did not show up to continue his 
treatment and further follow-ups. A careful investigation would be required including clinical findings, 
clinicopathological correlation, with appropriate radiological studies, before definitive treatment of ASPS. 
Conclusions: The main problem to gain an extended insight into clinical features and optimal treatment is the 
rarity of the disease. Given the ineffectiveness of current treatments in advanced ASPS, further future 
investigation to find new therapeutic options would be required. 
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(6,8). Certain other organs can be very unusually 
targeted by ASPS malignant cells including the female 
genital tract, mediastinum, breast, urinary bladder, 
gastrointestinal tract, retroperitoneum, and bones (8). 
The natural history of ASPS is a slow-growing 
painless tumor which runs an indolent course with a 
poor prognosis (7). ASPS is also characterized by 
unusual patterns of metastasis. Widespread metastasis 
may already be present at the time of diagnosis, leading 
to high mortality. Pulmonary metastases are 
encountered in 42-65% of patients. The brain and the 
skeleton are the two next most commonly involved 
metastatic sites (6). 
Here, we present a case of ASPS originated in the 
retroperitoneal space, along with radiological and 
pathological findings. 
Case Report 
A 31-year-old man was admitted to Imam Reza 
Hospital with a history of abdominal mass, nausea, and 
vomiting. He denied any weight loss or urinary 
discomfort. His medical and surgical histories were 
negative. Family history was negative too. Physical 
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Introduction
Alveolar soft part sarcoma (ASPS) is a rare malignant 
soft tissue neoplasm which accounts for < 1% of soft 
tissue sarcomas. It was initially described as 
a distinctive clinical entity by =DGQLN et al. in 
(1). This highly vascular tumor has a distinct 
morphology that clinically mimics hemangioma or 
arteriovenous malformation (2,3). The tumor received 
its name from its pseudo-alveolar appearance created 
by polygonal cells lacking central adhesion and 
abundant sinusoidal vessels. The term soft part is used 
to distinguish these sarcomas from bone sarcomas 
(4,5). 
It mainly affects adolescents and younger adults 
aged between 15 and 35 years, but the tumor can also 
occur in children as young as 2-year-old. There is a 
slight female predilection (6,7). 
ASPS has been reported in a wide variety of 
locations and it can present in soft tissues anywhere in 
the body. In young adults, most of the cases presents in 
the lower extremities, followed by the trunk and the 
upper limbs. Head and neck, especially the tongue and 
orbit, are more commonly found in pediatric ASPS 
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examination revealed an immobile mass with a smooth 
surface and about 10 cm × 5 cm in size, palpated in 
right lower quadrant (RLQ). His examinations were 
otherwise unremarkable. Laboratory findings were all 
within normal limits. Abdominal ultrasound revealed a 
mass measuring 8 cm × 5 cm × 7 cm in size at RLQ 
with hypervascularity. Both kidneys were normal in 
size and shape. Computed tomography (CT) scan 
studies demonstrated a hyper-dense mass with the 
necrotic center, 78 mm × 83 mm in diameter in the 
lower abdomen (Figure 1). Colonoscopy findings were 
normal. Ultrasound guided biopsy of the lesion was 
performed and revealed neuroendocrine tumor.  
As a locally aggressive sarcoma, it was decided that 
complete resection would yield the best chance of 
patient recovery and survival; resection of the tumor 
was performed via laparotomy; a well-defined mass in 
retroperitoneal space without adhesion to urethra or 
other organs was transected and sent to pathology for 
further analysis. Histopathology report was obtained as 
a poorly differentiated (high grade) adenocarcinoma 
consistent with high-grade renal cell carcinoma (RCC), 
which was incompatible with intraoperative and 
imaging data. There was no abnormality in both 
kidneys and no adhesion around the mass as it was 
observed during the operation. Therefore, we asked for 
a microscopic review and pathology then confirmed 
that the lesion was ASPS. All surgical margins also 
were free (Figures 2 and 3). The patient refused 
adjuvant chemotherapy and unfortunately he never 
showed up to continue his treatment and further 
follow-ups. 
Figure 1. Coronal reformat images of abdominal and pelvic computed tomography scan show retroperitoneal primary 
mass that operated about 2 years ago quadrant with central necrosis
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Figure 2. Organoid arrangement of tumor cells consist of 
sharply defined nests some with pseudoalveolar features 
separated by tiny sinusoidal vessels (H and E, ×100) 
Figure 3. Large polyhedral cells with sharp borders 
containing large round nuclei with prominent nucleoli and 
abundant granular and less vacuolar cytoplasm  
(H and E, ×400) 
Discussion 
ASPS has a characteristic histology with a nest-like 
organoid architecture separated by connective tissue 
septa that have a rich vascular network. Although these 
features are usually diagnostic of ASPS, on initial 
presentation, the ASPS may be difficult to distinguish 
from other tumors, especially when ASPS occurs in an 
unusual location, such as in the lung, stomach, 
retroperitoneum, and female genital tract. The 
following lesions should be considered in the 
differential diagnosis of ASPS, and they include 
paraganglioma, rhabdomyosarcoma, renal-cell 
carcinoma, metastatic adrenal carcinoma, clear-cell 
carcinoma, and melanoma. The ASPS needs to be 
differentiated from these tumors because the 
management strategy differs markedly for each tumor 
type. The discrimination of ASPS from these tumors is 
by demonstrating cytological uniformity, lack of 
nuclear atypia, and paucity of mitotic figures in ASPS 
(3,6,7). In this article, we report a 31-year-old man 
with ASPS firstly diagnosed as RCC. 
To accurate diagnosis and treatment of this unusual 
tumor careful investigation would be required, 
including clinical findings and clinicopathological 
correlation, with appropriate radiological studies. 
Histological workup includes the presence of 
characteristic periodic acid–Schiff and diastase-
positive intracellular crystals, immunehistochemical 
staining for melanocytic markers, and immune-
reactivity, e.g., antibodies, for S-100 protein (9). 
Recently, based on the fact that an unbalanced 
translocation, resulting in the ASPL-TFE3 fusion gene, 
is characteristic of ASPS, antibodies against the 
internal region of the TFE3 gene have been used to 
confirm the diagnosis of ASPS. Imaging workup 
including MRI, CT scan and vertebral X-ray may be 
mandatory in the diagnosis and further investigations 
of patients diagnosed with ASPS (10). 
Alveolar soft-part sarcoma is a very rare in the 
retroperitoneal space. Portera et al. reported that only 6 
(8%) of 70 ASPS patients treated from 1959 to 1998 at 
MD Anderson Cancer Center had ASPS of 
retroperitoneal space origin (11). According to a 
review done by Ishikawa et al., in 2006 (12), there 
were only four other cases of ASPS of retroperitoneal 
space origin in the literature. 
Unlike most sarcomas, ASPSs are characterized by 
their prominent metastatic potential. Metastases to the 
lungs and brain appear to be the most common site of 
metastasis in previous studies (5,11). Metastasis as 
initial presentation is common in these patients; the 
patients without metastasis at presentation may develop 
metastatic disease within follow-up period (13). 
The outcomes depend on factors such as a patient’s 
age, tumor size, stage, location, and the presence of 
metastasis at the time of diagnosis. Larger tumors and 
brain metastases make a significant difference in 
prognosis (11). The median survival is significantly 
higher among patients with no metastases compared 
with others who develop recurrence or metastatic 
disease (5,11). 
Early diagnosis, clinical staging are essential in the 
treatment of ASPS. In localized lesions with no 
metastases, surgical resection is the best option. The 
treatment options are limited when lesions are multiple, 
but for recurrence control, the first treatment option 
should be complete surgical resection as the single 
lesions. Although many studies showed no survival 
advantages from chemo or radiotherapy (10,11). 
Chemotherapy is commonly used in the treatment of 
unresectable advanced disease, with palliative 
intention. Adjuvant radiotherapy is also shown to be 
beneficial in this setting. Although it is impossible to 
draw conclusions definitely about the clinical value of 
adjuvant radiotherapy for ASPS treatment based on the 
rarity of the tumor (5). Therefore, it is apparent 
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alternative new therapeutic strategies, such as anti-
angiogenic agents given the rich vascular 
histopathology of the tumor, are mandatory for 
management and improve survival of patients with 
advanced ASPS (4,9). The standard treatment for and 
metastatic lesions in the brain and lung is surgical 
excision aiming at obtaining tumor-free margins and 
improve outcome (9). 
Conclusion 
Alveolar soft-part sarcoma is very rare in the 
retroperitoneal space. Due to its rarity, the diagnosis 
and treatment have been proven to be a challenge for 
the pathologist and the surgeon as well. The careful 
investigation would be required, including clinical 
findings, clinicopathological correlation, with 
appropriate radiological studies, before definitive 
treatment. Complete surgical excision with clear 
margins is the treatment of choice.
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